We are live on ! Find out more
IMA

ImageneBio Inc
IMA

40 hedge funds and large institutions have $42.6M invested in ImageneBio Inc in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $41.9M → $42.6M (+$647K)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.2% less ownership

Funds ownership: 6.51% → 6.32% (-0.2%)

11% less funds holding

Funds holding: 45 → 40 (-5)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
40
Holders Change
-5
Holders Change %
-11.11%
% of All Funds
0.53%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
8
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
+$391K
2
Citadel Advisors
Citadel Advisors
Florida
+$96.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$37K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$19.6K
5
Morgan Stanley
Morgan Stanley
New York
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
GS
Gilead Sciences
California
-$992K
2
PLC
Peapod Lane Capital
New York
-$379K
3
DCM
Deuterium Capital Management
Florida
-$103K
4
BP
BBR Partners
New York
-$89.6K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$58K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$6.72M – – –
BOCH
2
Blue Owl Capital Holdings
New York
$5.48M – – –
BCM
3
BML Capital Management
Indiana
$5.4M +$391K +26,608 +9%
BI
4
BVF Inc
California
$5.37M – – –
O
5
OrbiMed
New York
$4.74M – – –
DTC
6
Deep Track Capital
Connecticut
$3.37M – – –
OFM
7
Omega Fund Management
Massachusetts
$3.01M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.89M +$37K +2,519 +2%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$1.07M – – –
NMC
10
NEA Management Company
Maryland
$804K – – –
SI
11
Sofinnova Investments
California
$513K – – –
BlackRock
12
BlackRock
New York
$480K +$11.4K +775 +3%
GS
13
Gilead Sciences
California
$467K -$992K -67,550 -70%
Renaissance Technologies
14
Renaissance Technologies
New York
$414K +$17.6K +1,197 +5%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$413K -$11.2K -760 -3%
AC
16
Aldebaran Capital
Indiana
$324K -$6.96K -474 -2%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$278K – – –
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$265K -$58K -3,948 -19%
Citadel Advisors
19
Citadel Advisors
Florida
$212K +$96.1K +6,544 +99%
BCM
20
Bridgeway Capital Management
Texas
$205K – – –
Two Sigma Advisers
21
Two Sigma Advisers
New York
$193K -$8.95K -609 -5%
State Street
22
State Street
Massachusetts
$123K – – –
Squarepoint
23
Squarepoint
New York
$113K +$8.87K +604 +9%
UBS Group
24
UBS Group
Switzerland
$100K -$31.8K -2,166 -26%
Goldman Sachs
25
Goldman Sachs
New York
$89.3K -$12K -817 -13%
1
2

IMA Hedge Fund Activity: Q2 2025 in Review

40 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2025, worth a combined $42.6M — up 1.5% from $41.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of IMA and 4 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was BML Capital Management, adding an estimated $391K. The largest seller was Gilead Sciences, cutting an estimated $992K.

  • 40 institutional investors held ImageneBio Inc (IMA) as of Q2 2025, down from 45 in Q1 2025.
  • Funds reported $42.6M of ImageneBio Inc stock for Q2 2025, up 1.5% quarter-over-quarter.
  • 4 funds opened new ImageneBio Inc positions in Q2 2025 and 9 closed out, a net change of -5 holders.
  • The largest ImageneBio Inc buyer in Q2 2025 was BML Capital Management, an estimated $391K added.
  • The largest ImageneBio Inc seller in Q2 2025 was Gilead Sciences, an estimated $992K sold.

Based on aggregated 13F filings for Q2 2025.